Pioglitazone HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 26 USDMF, 10 CEP/COS, 10 JDMF, 17 EU WC, 26 KDMF, 16 NDC API, 14 Listed Suppliers, $ API Reference Price

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

160 FDF Dossiers, 77 FDA Orange Book, 36 Europe, 15 Canada, 2 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE, TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 27 BASF, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 41 Direct Compression, 32 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 27 Solubilizers, 27 Thickeners and Stabilizers, 26 Granulation, 22 Co-Processed Excipients, 20 Topical, 20 Parenteral, 20 Lubricants & Glidants, 18 Film Formers & Plasticizers, 17 Taste Masking, 15 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 8 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 18 Finished Drug Prices

MARKET PLACE

11 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 6 JP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22024 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
metformin hydrochloride(UNII: 786Z46389E) (metformin - UNII:9100L32L2N)	metformin hydrochloride	1000mg \| 1000mg
pioglitazone hydrochloride(UNII: JQT35NPK6C) (pioglitazone - UNII:X4OV71U42S)	pioglitazone	30mg \| 15mg

Inactive Ingredients

Ingredient Name	Takeda Pharmaceuticals America, Inc.
Aluminum Oxide(LMI26O6933)
ammonia(5138Q19F1X)
candelilla wax(WL0328HX19)
cellulose acetate(3J2P07GVB6)
FD&C Blue No. 2(L06K8R7DQK)
ferric oxide red(1K09F3G675)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
lactose monohydrate(EWQ57Q8I5X)
magnesium stearate(70097M6I30)
polyethylene glycol 400(B697894SGQ)
polyethylene glycol 8000(Q662QK8M3B)
POVIDONE, UNSPECIFIED(FZ989GH94E)
propylene glycol(6DC9Q167V3)
shellac(46N107B71O)
sodium lauryl sulfate(368GB5141J)
titanium dioxide(15FIX9V2JP)
triacetin(XHX3C3X673)

Drug Product Composition: Pioglitazone HCl